Clinical Trials Logo

Filter by:
NCT ID: NCT00197301 Completed - Influenza Clinical Trials

Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy

Start date: October 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Influnza vaccination is highly recommended over the age of 50,but is only 50% efficatious among the elderly. A Vaccine given as a nasal spray may improve compliance and local immunity.Liposomes are lipid particles that may serve as carriers for the vaccine and together they enhance the local immune response in mice when given as nasal spray.This study aims to examine the safety and nasal and humoral responses to the nasal vaccine compared to the commercial muscular vaccine.

NCT ID: NCT00196677 Terminated - Clinical trials for Glaucomatous Neuropathy

Study of Glaucoma Treatment With Food Additives

Start date: September 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if certain food additives are effective in the treatment of glaucoma, improving and reversing the progress of the disease.

NCT ID: NCT00192855 Completed - Schizophrenia Clinical Trials

Entacapone Augmentation for Schizophrenia

Start date: June 2003
Phase: N/A
Study type: Interventional

This study is testing the hypothesis that Entacapone added to ongoing antipsychotic treatment can be beneficial in schizophrenic patients with negative symptoms.

NCT ID: NCT00192829 Recruiting - Clinical trials for Venous Thromboembolism

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Start date: June 2005
Phase: N/A
Study type: Observational

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

NCT ID: NCT00192816 Recruiting - Clinical trials for Dementia Alzheimer Type

Pain Perception in Alzheimer's Disease

Start date: June 2005
Phase: N/A
Study type: Observational

The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nervous system reaction(reflected by the heart rate) in Alzheimer's disease. The study's hypothesis is that pain perception and autonomic nervous system reaction are altered in Alzheimer's disease.

NCT ID: NCT00192803 Not yet recruiting - NIDDM Clinical Trials

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

Start date: n/a
Phase: Phase 4
Study type: Interventional

This feasibility study is designed to examine modulation of the relative activities of ACE and ACE2 in diabetic patients following treatment with the angiotensin type 1 receptor (AT1R) antagonist, Candesartan. This study will provide a closer insight to the possible involvement of the renin-angiotensin system (RAS)-related enzymatic components in development or attenuation of vascular pathogenesis.

NCT ID: NCT00192790 Completed - Clinical trials for Myocardial Infarction

Pain Perception is Attenuated in Patients With Painless Myocardial Infarction

Start date: January 2004
Phase: N/A
Study type: Observational

To explore whether reduced systemic pain perception in response to painful stimuli and personality pain related variables characterizes silent MI patients.

NCT ID: NCT00192777 Recruiting - Solid Tumors Clinical Trials

Concurrent Xeloda and Radiotherapy for Bone Metastases

Start date: November 2004
Phase: Phase 2
Study type: Interventional

Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief. Primary Objective: - To determine the frequency of pain relief for the proposed regimen. Secondary Objective(s): - To determine the duration of pain relief and narcotic relief for the proposed regimen. - To determine the frequency of narcotic relief for the proposed regimen. - To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases.

NCT ID: NCT00192764 Completed - Clinical trials for Non-Hodgkin's Lymphoma

High Dose CHOP in Lymphoma

Start date: December 1996
Phase: Phase 2
Study type: Interventional

The study hypothesis is that intensification of CHOP by dose escalation of the most active drugs in the combination will improve treatment outcome. Patients with diffuse large-cell lymphoma are treated by high cyclophosphamide containing CHOP. The planned dose is 3000 mg/m2 which is 4 times the atandard one. Only 4 cycles are given.

NCT ID: NCT00192751 Recruiting - Clinical trials for Patients Diagnosed With Severe Mental Illness

From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management

Start date: February 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the benefit and impact on relapse prevention,adherence to treatment and general health indices of participation in psycho-eduational group intervention among psychiatric patients with severe mental illness,recently discharged from inpatient services.